Evidence map›Paper›PMID 36619789›Full record

ArticleComputational and mathematical methods in medicine2022

Network Pharmacology, Molecular Docking, and Molecular Dynamic-Based Investigation on the Mechanism of Compound Chrysanthemum in the Treatment of Asthenopia.

Junjie Qiu, Biying Zheng, Hengpu Zhou, Chengcong Ye, Menglin Shi, Senlin Shi, Suxiang Wu

Open access · hybridAbstract read
In one paragraph

Article in Computational and mathematical methods in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Junjie QiuSchool of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 311402, China.ORCID https://orcid.org/0000-0003-0902-102X
Biying ZhengSchool of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 311402, China.ORCID https://orcid.org/0000-0002-1404-7868
Hengpu ZhouSchool of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 311402, China.ORCID https://orcid.org/0000-0002-4409-661X
Chengcong YeSchool of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 311402, China.ORCID https://orcid.org/0000-0002-3796-2639
Menglin ShiSchool of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 311402, China.ORCID https://orcid.org/0000-0002-5803-2991
Senlin ShiSchool of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 311402, China.ORCID https://orcid.org/0000-0003-3608-3496
Suxiang WuSchool of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 311402, China.ORCID https://orcid.org/0000-0002-3526-209X
Zhejiang Chinese Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As a clinical empirical prescription for ophthalmology, compound chrysanthemum has been used gradually and has a good effect on eye fatigue. However, the detailed mechanisms of antiasthenopia have not been studied. In order to clarify the mechanisms of the compound chrysanthemum in the treatment of asthenopia, network pharmacology was combined with experimental study in this paper. A total of 593 genes and 39 active chemicals were identified, and both were considered to be essential to the advancement of asthenopia research. The results of the molecular docking analysis demonstrated a certain affinity between PRKACA, PRKCA, PRKCB, and their related compounds; molecular dynamic simulations assessed the stability of these receptors and ligands. The effects of compound chrysanthemum extract on ciliary muscle were studied in vitro and in vivo. By using the MTT assay, compound chrysanthemum extracts (50, 100, 200, 400, and 800 g·mL-1) showed no effect on the proliferation of rCSMCs for 24 and 48 hours. It raised nitric oxide and decreased Ca

Indexed as

AsthenopiaChrysanthemumDrugs, Chinese HerbalAnimalsMolecular Docking SimulationMolecular Dynamics SimulationNetwork PharmacologyRatsRats, Sprague-DawleyDrugs, Chinese Herbal

Identifiers

PMID36619789
PMCPMC9822747
OpenAlexW4313410145

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.